Targeting MLL-CXXC Domain with Synthetic CpG Dinucleotides: Docking and Molecular Dynamics Simulation Based Approach

Medha D. Pandya; Shweta D. Dabhi; Prafulla K. Jha; Rakesh Rawal

doi:10.4028/www.scientific.net/AMR.1141.115

Paper Titles

Influence of Swift Heavy O⁷⁺ Ion Irradiation on Conductivity and Relaxation Dynamics of Two Different Blends of PVA:PEO:LiCF₃SO₃:EC System
p.96

Growth and Electrical Characterizations of Sn_0.3Se_0.7 Crystals Grown by Direct Vapour Transport Technique
p.103

The Theoretical Study of High Pressure Equation of State and Relative Volume Thermal Expansion of fcc Transition Metals Ni, Pd and Pt Using Mean Field Potential Approach
p.107

Study of LSMO Ceramics through Different Synthesis Route
p.111

Targeting MLL-CXXC Domain with Synthetic CpG Dinucleotides: Docking and Molecular Dynamics Simulation Based Approach
p.115

Theoretical Modelling of Equations of States for Aluminum to Pressure up to 10 TPa and Temperature to 10 eV
p.121

Study of Molecular Interaction in Binary Mixtures (1-Propanol + Acetophenone)
p.125

Prediction of Static Dielectric Constant (ε₀) and Refractive Index (n) Using Various Models for Binary Mixtures (Acetophenone with N-Hexanol)
p.131

Thermal and Optical Properties of Glycine Crystals with Additives of Nitrates
p.136

HomeAdvanced Materials ResearchAdvanced Materials Research Vol. 1141Targeting MLL-CXXC Domain with Synthetic CpG...

Targeting MLL-CXXC Domain with Synthetic CpG Dinucleotides: Docking and Molecular Dynamics Simulation Based Approach

Abstract:

Mixed lineage leukemia (MLL) is an aggressive type of childhood leukemia characterized by the presence of MLL fusion proteins resultant of chromosomal translocations affecting the MLL gene. These resulting chimeric proteins act as transcriptional regulators that take control of MLL targets. MLL fuses with more than 60 different partner genes, these fusion proteins retain the CXXC domain which binds to nonmethylated CpG DNA. The Molecular docking of CXXC domain and CpG dinucleotides were performed, large scale and long time (10 ns each) molecular dynamics simulation on CXXC domain wild type and AF9-MLL Fusion Protein have been performed to study the mechanism at atomic level. The effects of point mutation on DNA bindings were also studied through Molecular Docking. The results confirm that this point mutation have efficacy of interrupt the DNA bindings. Moreover, in-silico studies suggest external synthetic CpG DNA efficiently binds to CXXC domain and may be potential lead molecule for further in-vitro studies.

You might also be interested in these eBooks

View Preview

Info:

Periodical:

Advanced Materials Research (Volume 1141)

Pages:

115-120

DOI:

https://doi.org/10.4028/www.scientific.net/AMR.1141.115

Citation:

Cite this paper

Online since:

August 2016

Authors:

Medha D. Pandya, Shweta D. Dabhi, Prafulla K. Jha, Rakesh Rawal*

Keywords:

Docking, MLL CXXC Domain, Molecular Dynamics, Oncogenic Fusion Protein, Simulation, Synthetic DNA

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

* - Corresponding Author

References

[1] J. D. Rowley, The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32 (1998) 495-519.

DOI: 10.1146/annurev.genet.32.1.495

Google Scholar

[2] P. Ernst, J. Wang, S. J. Korsmeyer, The role of MLL in hematopoiesis and leukemia. Curr. Opin. Hematol. 9 (2002) 282-7.

Google Scholar

[3] P. H. Sorensen, et al. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J. Clin. Invest. 93 (1994) 429–437.

DOI: 10.1172/jci116978

Google Scholar

[4] M. C. Cox, et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am. J. Clin. Pathol. 122 (2004) 298–306.

DOI: 10.1309/rx27r8gjqm330c22

Google Scholar

[5] O. Bernard, R. Berger, Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes, Chromosomes and Cancer. 13 (1995) 75–85.

DOI: 10.1002/gcc.2870130202

Google Scholar

[6] P. M. Ayton, E. H. Chen, M. L. Cleary. Binding to nonmethylatedCpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein, Mol. Cell Biol. 24, 23, (2004) 10470-8.

DOI: 10.1128/mcb.24.23.10470-10478.2004

Google Scholar

[7] F. E. Erfurth, R. Popovic, J. Grembecka, et al. MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. Proc. Natl. Acad. Sci. USA. 105 (2008) 7517-7522.

DOI: 10.1073/pnas.0800090105

Google Scholar

[8] S. A. Armstrong, J. E. Staunton, L. B. Silverman, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30 (2002) 41-47.

DOI: 10.1038/ng765

Google Scholar

[9] ACD/ChemSketch Freeware, version 11. 00, Advanced Chemistry Development, Inc., Toronto, ON, Canada, www. acdlabs. com, (2015).

Google Scholar

[10] R. Thomsen, M. H. Christensen, MolDock: A new technique for high-accuracy molecular docking. J. Med. Chem. 49(2006) 3315-3321.

DOI: 10.1021/jm051197e

Google Scholar

[11] M. Dave, A. Daga, R. Rawal, Structural and functional analysis of AF9-MLL oncogenic fusion protein using homology modeling and simulation based approach. Int. J. pharm. Pharm. sci. 7, 12, (2015) 155-161.

Google Scholar

[12] B. Hess, C. Kutzner, D. E. van der Spoel, E. Lindahl, GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory. Comput. 4 (2008) 435–447.

DOI: 10.1021/ct700301q

Google Scholar

[13] W. L. Jorgensen, J. Tirado-Rives, The OPLS potential functions for proteins. energy minimizationsfor crystals of cyclic peptides andcrambin, J. Am. Chem. Soc. 110(1988) 1657–1666.

DOI: 10.1021/ja00214a001

Google Scholar

[14] T. Cierpicki, L. E. Risner, J. Grembecka, S. M. Lukasik, R. Popovic, M. Omonkowska, D. D. Shultis, N. J. Zeleznik-Le and J. H. Bushweller, Structure of the MLL CXXC domain – DNA complex and its functional role in MLL-AF9 leukemia. Nat. Struct. Mol. Biol. 17 (2010).

DOI: 10.1038/nsmb.1714

Google Scholar